The Procter & Gamble Company (NYSE:PG) Shares Sold by New Century Financial Group LLC

New Century Financial Group LLC lowered its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 17.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,846 shares of the company’s stock after selling 1,052 shares during the period. New Century Financial Group LLC’s holdings in Procter & Gamble were worth $839,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Steele Capital Management Inc. acquired a new stake in shares of Procter & Gamble during the 1st quarter worth about $204,000. GAMMA Investing LLC lifted its holdings in shares of Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after purchasing an additional 10,777 shares during the last quarter. Consilio Wealth Advisors LLC boosted its position in shares of Procter & Gamble by 27.7% in the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock valued at $283,000 after purchasing an additional 379 shares during the period. AMF Tjanstepension AB grew its stake in Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after buying an additional 1,466,115 shares during the last quarter. Finally, Talbot Financial LLC increased its position in Procter & Gamble by 1.5% during the first quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock worth $10,644,000 after buying an additional 950 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock valued at $65,140,718 over the last quarter. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Price Performance

PG stock opened at $171.28 on Friday. The company has a market cap of $404.24 billion, a price-to-earnings ratio of 27.99, a PEG ratio of 3.74 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $171.77 and a 200-day moving average of $167.16. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.83 earnings per share. As a group, equities analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s payout ratio is currently 65.69%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PG. Piper Sandler initiated coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. increased their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Royal Bank of Canada boosted their price target on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research report on Wednesday, July 31st. Finally, BNP Paribas initiated coverage on Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 target price on the stock. Nine investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $176.21.

View Our Latest Research Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.